302 related articles for article (PubMed ID: 28521841)
1. TNF inhibitors appear to inhibit disease progression and improve outcome in Takayasu arteritis; an observational, population-based time trend study.
Gudbrandsson B; Molberg Ø; Palm Ø
Arthritis Res Ther; 2017 May; 19(1):99. PubMed ID: 28521841
[TBL] [Abstract][Full Text] [Related]
2. Serial analysis of clinical and imaging indices reveals prolonged efficacy of TNF-α and IL-6 receptor targeted therapies in refractory Takayasu arteritis.
Youngstein T; Peters JE; Hamdulay SS; Mewar D; Price-Forbes A; Lloyd M; Jeffery R; Kinderlerer AR; Mason JC
Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S11-8. PubMed ID: 24093733
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Biological-Targeted Treatments in Takayasu Arteritis: Multicenter, Retrospective Study of 49 Patients.
Mekinian A; Comarmond C; Resche-Rigon M; Mirault T; Kahn JE; Lambert M; Sibilia J; Néel A; Cohen P; Hie M; Berthier S; Marie I; Lavigne C; Anne Vandenhende M; Muller G; Amoura Z; Devilliers H; Abad S; Hamidou M; Guillevin L; Dhote R; Godeau B; Messas E; Cacoub P; Fain O; Saadoun D;
Circulation; 2015 Nov; 132(18):1693-700. PubMed ID: 26354797
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of 251 patients with Takayasu arteritis on combination immunosuppressant therapy: Single centre experience from a large tertiary care teaching hospital in Southern India.
Goel R; Danda D; Joseph G; Ravindran R; Kumar S; Jayaseelan V; Jayaseelan L; Bacon P
Semin Arthritis Rheum; 2018 Apr; 47(5):718-726. PubMed ID: 29096935
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup.
Schmidt J; Kermani TA; Bacani AK; Crowson CS; Matteson EL; Warrington KJ
Arthritis Care Res (Hoboken); 2012 Jul; 64(7):1079-83. PubMed ID: 22328491
[TBL] [Abstract][Full Text] [Related]
6. Management of Takayasu arteritis.
Misra DP; Singh K; Rathore U; Kavadichanda CG; Ora M; Jain N; Agarwal V
Best Pract Res Clin Rheumatol; 2023 Mar; 37(1):101826. PubMed ID: 37246052
[TBL] [Abstract][Full Text] [Related]
7. Takayasu arteritis: a cohort of Italian patients and recent pathogenetic and therapeutic advances.
Dammacco F; Cirulli A; Simeone A; Leone P; Pulli R; Angiletta D; Rubini G; Di Palo A; Vacca A; Dammacco R
Clin Exp Med; 2021 Feb; 21(1):49-62. PubMed ID: 33026580
[TBL] [Abstract][Full Text] [Related]
8. Childhood Takayasu arteritis: disease course and response to therapy.
Aeschlimann FA; Eng SWM; Sheikh S; Laxer RM; Hebert D; Noone D; Twilt M; Pagnoux C; Benseler SM; Yeung RSM
Arthritis Res Ther; 2017 Nov; 19(1):255. PubMed ID: 29166923
[TBL] [Abstract][Full Text] [Related]
9. Childhood-onset Takayasu arteritis: A 15-year experience from a tertiary referral center.
Sahin S; Hopurcuoglu D; Bektas S; Belhan E; Adrovic A; Barut K; Canpolat N; Caliskan S; Sever L; Kasapcopur O
Int J Rheum Dis; 2019 Jan; 22(1):132-139. PubMed ID: 30397997
[TBL] [Abstract][Full Text] [Related]
10. Infantile Takayasu: clinical features and long-term outcome.
Miller-Barmak A; Sztajnbok F; Balik Z; Borzutzky A; Fogel LA; Goldzweig O; Ozen S; Butbul Aviel Y
Rheumatology (Oxford); 2023 Sep; 62(9):3126-3132. PubMed ID: 36495199
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of tocilizumab and its comparison with tumor necrosis factor alpha inhibitors for Takayasu Arteritis: A systematic review and meta-analysis.
Misra DP; Singh K; Rathore U; Patro P; Tomelleri A; Campochiaro C; Agarwal V; Sharma A
Autoimmun Rev; 2023 Mar; 22(3):103275. PubMed ID: 36652977
[TBL] [Abstract][Full Text] [Related]
12. A retrospective cohort study to assess PET-CT findings and clinical outcomes in Takayasu arteritis: does 18F-fluorodeoxyglucose uptake in arteries predict relapses?
Janes ALF; Castro MF; Arraes AED; Savioli B; Sato EI; de Souza AWS
Rheumatol Int; 2020 Jul; 40(7):1123-1131. PubMed ID: 32200427
[TBL] [Abstract][Full Text] [Related]
13. Childhood-onset Takayasu arteritis -- experience from a tertiary care center in South India.
Goel R; Kumar TS; Danda D; Joseph G; Jeyaseelan V; Surin AK; Bacon P
J Rheumatol; 2014 Jun; 41(6):1183-9. PubMed ID: 24786922
[TBL] [Abstract][Full Text] [Related]
14. Infliximab in Takayasu arteritis: a safe alternative?
Karageorgaki ZT; Mavragani CP; Papathanasiou MA; Skopouli FN
Clin Rheumatol; 2007 Jun; 26(6):984-7. PubMed ID: 16633710
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients.
Schmidt J; Kermani TA; Bacani AK; Crowson CS; Cooper LT; Matteson EL; Warrington KJ
Mayo Clin Proc; 2013 Aug; 88(8):822-30. PubMed ID: 23849994
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up.
Molloy ES; Langford CA; Clark TM; Gota CE; Hoffman GS
Ann Rheum Dis; 2008 Nov; 67(11):1567-9. PubMed ID: 18677012
[TBL] [Abstract][Full Text] [Related]
17. Medication Persistence of Disease-Modifying Antirheumatic Drugs and Anti-Tumor Necrosis Factor Agents in a Cohort of Patients With Rheumatoid Arthritis in Brazil.
Acurcio FA; Machado MA; Moura CS; Ferre F; Guerra AA; Andrade EI; Cherchiglia ML; Rahme E
Arthritis Care Res (Hoboken); 2016 Oct; 68(10):1489-96. PubMed ID: 26814681
[TBL] [Abstract][Full Text] [Related]
18. Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis.
Pan L; Du J; Liu J; Liao H; Liu X; Guo X; Liang J; Han H; Yang L; Zhou Y
Clin Rheumatol; 2020 Aug; 39(8):2369-2378. PubMed ID: 32144625
[TBL] [Abstract][Full Text] [Related]
19. Extra-cranial giant cell arteritis and Takayasu arteritis: How similar are they?
Kermani TA; Crowson CS; Muratore F; Schmidt J; Matteson EL; Warrington KJ
Semin Arthritis Rheum; 2015 Jun; 44(6):724-8. PubMed ID: 25712813
[TBL] [Abstract][Full Text] [Related]
20. Th1 and Th17 cytokines drive inflammation in Takayasu arteritis.
Saadoun D; Garrido M; Comarmond C; Desbois AC; Domont F; Savey L; Terrier B; Geri G; Rosenzwajg M; Klatzmann D; Fourret P; Cluzel P; Chiche L; Gaudric J; Koskas F; Cacoub P
Arthritis Rheumatol; 2015 May; 67(5):1353-60. PubMed ID: 25604824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
